FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119349610> ?p ?o ?g. }

• W3119349610 abstract "Flavonoids, a subclass of polyphenols, have been shown to be effective against several types of cancer, by decreasing proliferation and inducing apoptosis. Therefore, the aim of the present study was to assess the anti‑carcinogenic potential of luteolin on HeLa human cervical cancer cells, through the use of a cell viability assay, DNA fragmentation assay, mitochondrial membrane potential assay, cell cycle analysis using Annexin/PI staining and flow cytometry, gene expression analysis and a protein profiling array. Luteolin treatment exhibited cytotoxicity towards HeLa cells in a dose‑ and time‑dependent manner, and its anti‑proliferative properties were confirmed by accumulation of luteolin‑treated cells in sub‑G1 phases. Cytotoxicity induced by luteolin treatment resulted in apoptosis, which was mediated through depolarization of the mitochondrial membrane potential and DNA fragmentation. Furthermore, luteolin treatment increased the expression of various proapoptotic genes, including <em>APAF1</em>, <em>BAX</em>, <em>BAD</em>, <em>BID</em>, <em>BOK</em>, <em>BAK1</em>, <em>TRADD</em>, <em>FADD</em>, <em>FAS</em>, and <em>Caspases 3</em> and <em>9</em>, whereas the expression of anti‑apoptotic genes, including <em>NAIP</em>, <em>MCL‑1</em> and <em>BCL‑2</em>, was decreased. Cell cycle regulatory genes, including <em>CCND1</em>, <em>2</em> and <em>3</em>, <em>CCNE2</em>, <em>CDKN1A</em>, <em>CDKN2B</em>, <em>CDK4</em> and <em>CDK2</em>, were decreased following treatment. Expression of TRAILR2/DR5, TRAILR1/DR4, Fas/TNFRSF6/CD95 and TNFR1/TNFRSF1A, as well as pro‑apoptotic proteins, including BAD, BAX and Cytochrome C were consistently increased, and the expression of antiapoptotic proteins, HIF1α, BCL‑X, MCL1 and BCL2, were found to be decreased following treatment. Expression of <em>AKT1</em> and <em>2</em>, <em>ELK1</em>, <em>PIK3C2A</em>, <em>PIK3C2B</em>, <em>MAPK14</em>, <em>MAP3K5</em>, <em>MAPK3</em> and <em>MAPK1</em> was significantly decreased at the transcriptional level. Expression of GSK3b (p‑ser9), PRAS 40 (p‑Ther246), BAD (p‑ser112), PTEN (p‑ser380), AKT (p‑ser473), ERK2 (p‑Y185/Y187), RISK2 (p‑ser386), P70S6k (p‑Thr421/ser424), PDK1(p‑ser241), ERK1 (p‑T202/Y204) and MTOR (p‑ser2448) was downregulated and expression of P53 (p‑ser241) and P27(p‑Thr198) was upregulated by luteolin in a dose‑dependent manner, indicating its anti‑proliferative and apoptosis enabling properties, and this may have been mediated via inhibition of the AKT and the MAPK pathways." @default.
• W3119349610 created "2021-01-18" @default.
• W3119349610 creator A5011801765 @default.
• W3119349610 creator A5024145910 @default.
• W3119349610 creator A5053008837 @default.
• W3119349610 creator A5068811021 @default.
• W3119349610 creator A5069163485 @default.
• W3119349610 creator A5070877765 @default.
• W3119349610 creator A5076159402 @default.
• W3119349610 creator A5085714957 @default.
• W3119349610 date "2021-01-07" @default.
• W3119349610 modified "2023-10-12" @default.
• W3119349610 title "Luteolin inhibits proliferation, triggers apoptosis and modulates Akt/mTOR and MAP kinase pathways in HeLa cells" @default.
• W3119349610 cites W1990408513 @default.
• W3119349610 cites W2012455446 @default.
• W3119349610 cites W2027156218 @default.
• W3119349610 cites W2037070328 @default.
• W3119349610 cites W2048256263 @default.
• W3119349610 cites W2048448304 @default.
• W3119349610 cites W2064236386 @default.
• W3119349610 cites W2070468167 @default.
• W3119349610 cites W2075938797 @default.
• W3119349610 cites W2087326187 @default.
• W3119349610 cites W2103373547 @default.
• W3119349610 cites W2125525736 @default.
• W3119349610 cites W2127319233 @default.
• W3119349610 cites W2134855813 @default.
• W3119349610 cites W2141105144 @default.
• W3119349610 cites W2141144639 @default.
• W3119349610 cites W2149880101 @default.
• W3119349610 cites W2163577434 @default.
• W3119349610 cites W2218128634 @default.
• W3119349610 cites W2221898953 @default.
• W3119349610 cites W2275405268 @default.
• W3119349610 cites W2296923571 @default.
• W3119349610 cites W2299870789 @default.
• W3119349610 cites W2318062977 @default.
• W3119349610 cites W2329681473 @default.
• W3119349610 cites W2339667234 @default.
• W3119349610 cites W2403866096 @default.
• W3119349610 cites W2496018230 @default.
• W3119349610 cites W2507321490 @default.
• W3119349610 cites W2510413148 @default.
• W3119349610 cites W2521105332 @default.
• W3119349610 cites W2531623456 @default.
• W3119349610 cites W2570656947 @default.
• W3119349610 cites W2591743873 @default.
• W3119349610 cites W2625614704 @default.
• W3119349610 cites W2725236242 @default.
• W3119349610 cites W2730053957 @default.
• W3119349610 cites W2745559177 @default.
• W3119349610 cites W2765101740 @default.
• W3119349610 cites W2771136768 @default.
• W3119349610 cites W2790583891 @default.
• W3119349610 cites W2803519014 @default.
• W3119349610 cites W2888561138 @default.
• W3119349610 cites W2902671415 @default.
• W3119349610 cites W2906581829 @default.
• W3119349610 cites W2907688525 @default.
• W3119349610 cites W2917968580 @default.
• W3119349610 cites W2923047376 @default.
• W3119349610 cites W2966641116 @default.
• W3119349610 cites W2991128282 @default.
• W3119349610 doi "https://doi.org/10.3892/ol.2021.12452" @default.
• W3119349610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7816384" @default.
• W3119349610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33574931" @default.
• W3119349610 hasPublicationYear "2021" @default.
• W3119349610 type Work @default.
• W3119349610 sameAs 3119349610 @default.
• W3119349610 citedByCount "26" @default.
• W3119349610 countsByYear W31193496102021 @default.
• W3119349610 countsByYear W31193496102022 @default.
• W3119349610 countsByYear W31193496102023 @default.
• W3119349610 crossrefType "journal-article" @default.
• W3119349610 hasAuthorship W3119349610A5011801765 @default.
• W3119349610 hasAuthorship W3119349610A5024145910 @default.
• W3119349610 hasAuthorship W3119349610A5053008837 @default.
• W3119349610 hasAuthorship W3119349610A5068811021 @default.
• W3119349610 hasAuthorship W3119349610A5069163485 @default.
• W3119349610 hasAuthorship W3119349610A5070877765 @default.
• W3119349610 hasAuthorship W3119349610A5076159402 @default.
• W3119349610 hasAuthorship W3119349610A5085714957 @default.
• W3119349610 hasBestOaLocation W31193496101 @default.
• W3119349610 hasConcept C1491633281 @default.
• W3119349610 hasConcept C153911025 @default.
• W3119349610 hasConcept C190283241 @default.
• W3119349610 hasConcept C2776055636 @default.
• W3119349610 hasConcept C2776080593 @default.
• W3119349610 hasConcept C2777366897 @default.
• W3119349610 hasConcept C2778004101 @default.
• W3119349610 hasConcept C2781263971 @default.
• W3119349610 hasConcept C29537977 @default.
• W3119349610 hasConcept C31573885 @default.
• W3119349610 hasConcept C43759708 @default.
• W3119349610 hasConcept C502942594 @default.
• W3119349610 hasConcept C55493867 @default.
• W3119349610 hasConcept C86554907 @default.
• W3119349610 hasConcept C86803240 @default.
• W3119349610 hasConcept C95444343 @default.
• W3119349610 hasConcept C98424977 @default.

• next